14-ou dip rp-accpr 4.01 clinical conseqences accid exposures web

71
IAEA International Atomic Energy Agency PREVENTION OF ACCIDENTAL EXPOSURE IN RADIOTHERAPY Part 4: Clinical consequences of accidental exposures in radiotherapy IAEA Training Course

Upload: sandya-sandy

Post on 05-Apr-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 1/71

IAEAInternational Atomic Energy Agency

PREVENTION OF ACCIDENTALEXPOSURE IN RADIOTHERAPY

Part 4: Clinical consequences of accidentalexposures in radiotherapy

IAEA Training Course

Page 2: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 2/71

IAEA

Prevention of accidental exposure in radiotherapy 2

Overview / Objectives

• Module 4.1: Clinical consequences of accidentalexposures in radiotherapy

Objectives:

To provide basic knowledge of clinical consequencesfrom the major case histories and to outline the

clinical detection of radiotherapy accidents

Page 3: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 3/71

IAEAInternational Atomic Energy Agency

Module 4.1: Clinical consequences ofaccidental exposures in radiotherapy

IAEA Training Course

Page 4: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 4/71

IAEA

Prevention of accidental exposure in radiotherapy 4

Outline

• Therapeutic ratio

• Acute and late reactions

• Normal tissue tolerance and reaction scoring

• Accidental under- and over-exposure

• Clinical consequences• Organ specific

• Clinical detection of accidental exposure• Lessons & recommendations

Page 5: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 5/71

IAEA

Prevention of accidental exposure in radiotherapy 5

Therapeutic ratioin radical radiotherapy

• Radiation doses given for curative treatmentof cancers are at the limit of normal tissuetolerance.

• Late complications can be expected for acertain proportion of cure rate.

Page 6: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 6/71

IAEA

Prevention of accidental exposure in radiotherapy 6

0.0

0.2

0.4

0.6

0.8

1.0

0 20 40 60 80 100

Absorbed Dose (Gy)

Tissue response vs. absorbed dose

D1 = Low cures, no complications

D3 = High cures high complications

D2 = Moderate cures, minimal complications

Tumour control

Normal tissue damage

Page 7: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 7/71

IAEA Prevention of accidental exposure in radiotherapy 7

Therapeutic ratioin radical radiotherapy

• “Acceptable” complications depend on

• Rate of complications

• Organ concerned

• Severity of effect

• The risk level may differ between cliniciansand patients

• Usual acceptable level is 5%

• Lower levels are accepted for serious complicationse.g. spinal myelitis

Page 8: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 8/71

IAEA Prevention of accidental exposure in radiotherapy 8

Side-effects & complicationsof radiotherapy

• Radiation reactions are divided according totime scale

• Acute - < 6 months from exposure

• Sub-acute - 6 - 12 months post-exposure

• Late - > 12 months post-exposure

Page 9: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 9/71

IAEA Prevention of accidental exposure in radiotherapy 9

Acute reactions

• Acute reactions are a part of normal radiotherapy.

• Less important as they are usually minor and transient

• Usually observed in tissues with rapid cell turnover

(skin, mucosa, bone marrow …) • Due to decreased cell replacement

• Manifested according to normal tissue turn-over time

• Overexposure may increase the frequency andseverity (up to necrosis)

Page 10: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 10/71

IAEA Prevention of accidental exposure in radiotherapy 10

Acute reactions

• Determinant factors for acute reactions are:• 1) total delivered dose

• 2) total time of exposure

• 3) organ concerned

• 4) size of irradiated volume

• 5) concomitant drugs (chemotherapy) or disease, e.g. diabetes, previous surgery

• For a given dose, little correlation of early reactionswith fraction size unless fraction size is high

• For specified doses that are protracted, damage isreduced

Page 11: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 11/71

IAEA Prevention of accidental exposure in radiotherapy 11

Acute reactions

• Usually do not correlatewith late effects thereforerelatively high frequencyacceptable

• Except when reactions aresevere leading toconsequential latereactions

• Examples:• mucositis

• skin changes

Page 12: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 12/71

IAEA Prevention of accidental exposure in radiotherapy 12

Acute reactions - reporting

• Evaluation of radiation reactions are mostlysubjective

• To enhance uniformity, reactions are graded

• e.g. skin grade 2, mucosa grade 1• Commonly used scales include:

• NCIC

• RTOG• EORTC

• LENT-SOMA

Page 13: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 13/71

IAEA Prevention of accidental exposure in radiotherapy 13

Acute Morbidity Scoring SystemGrade [ 0 ]  [ 1 ]  [ 2 ]  [ 3 ]  [ 4 ] 

UPPERG.I. 

Nochange 

Anorexia with<=5% weight

loss frompretreatmentbaseline/ nauseanot requiringantiemetics/ abdominaldiscomfort notrequiringparasympatholyti

c drugs oranalgesics 

Anorexia with <=15%weight loss from

pretreatmentbaseline/nausea &/ orvomiting requiringantiemetics/ abdominalpain requiringanalgesics 

Anorexia with >15% weightloss from pretreatment

baseline or requiring N-Gtube or parenteral support.Nausea &/or vomitingrequiring tube or parenteralsupport/abdominal pain,severe despitemedication/hematemesis ormelena/ abdominaldistention (flat plate

radiograph demonstratesdistended bowel loops 

Ileus, subacute oracute obstruction,

performation, GIbleeding requiringtransfusion/abdominalpain requiring tubedecompression orbowel diversion 

LOWERG.I. INCL.PELVIS 

Nochange 

Increasedfrequency orchange in qualityof bowel habitsnot requiring

medication/ rectal discomfortnot requiringanalgesics 

Diarrhea requiringparasympatholyticdrugs (e.g., Lomotil)/ mucous discharge notnecessitating sanitary

pads/ rectal orabdominal painrequiring analgesics 

Diarrhea requiringparenteral support/ severemucous or blood dischargenecessitating sanitarypags/abdominal distention

(flat plate radiographdemonstrates distendedbowel loops) 

Acute or subacuteobstruction, fistula orperforation; GI bleedingrequiring transfusion;abdominal pain or

tenesmus requiringtube decompression orbowel diversion 

Example for some tissues from the RTOGAcute Morbidity Scoring System

Page 14: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 14/71

IAEA Prevention of accidental exposure in radiotherapy 14

Reaction grading summary

Grade Symptoms Intervention Radiation

0 Nil Nil Cont.

1 Mild Nil Cont.

2 Moderate Medication Cont.

3 Severe Supportive ?Delay / Stop

4Life

threateningSupportive ++ Stop

Page 15: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 15/71

IAEA Prevention of accidental exposure in radiotherapy 15

Acute side effects - grades

Grade 1

Erythema

Grade 2

Drydesquamation

Grade 3Moist

desquamation

Grade 4Necrosis

Page 16: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 16/71

IAEA Prevention of accidental exposure in radiotherapy 16

Late reactions

• Manifest >12 monthsfrom exposure

• but may occur earlierif severe overdose

• Incidence increasesover time

Bladder and rectal complicationsfollowing radiotherapy for cervical cancer

Page 17: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 17/71

IAEA Prevention of accidental exposure in radiotherapy 17

Late reactions

• Mainly observed in tissues with slowly proliferating cells• complications are due to arteriolar / capillary narrowing which occur

over time• causes hypoxic damage

• Late complications can also manifest on rapidly

proliferating cells• in addition to and after acute effects

• They are irreversible and often slowly progressive• late reacting tissue are considered as dose-limiting for conventional

radiotherapy

• Late complications can also be consequential to severeacute reactions• they are slowly progressive, and potentially possible to delay using

vascular modifiers

Page 18: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 18/71

IAEA Prevention of accidental exposure in radiotherapy 18

Late reactions

• Determinant factors:• total delivered dose

• fraction size and dose rate

• In the case of accidental exposure, the increasedfraction size may amplify the effects (this was thecase in some accidents)

• Late responding tissue are more sensitive toincreases in fraction size than are early reacting

tissues (low α / β ratio)

• organ concerned• e.g. nervous system, lung, rectum, bladder

Page 19: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 19/71

IAEA Prevention of accidental exposure in radiotherapy 19

Late reactions

• In serial organs (spinal cord,intestine, large arteries), alesion of a small volumeirradiated above threshold

may cause major incapacity,for example paralysis

• In organs arranged in parallel,such as lung and liver,

severity is related to theirradiated tissue volumeabove threshold

Page 20: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 20/71

IAEA Prevention of accidental exposure in radiotherapy 20

Late reactions

• Complications aremore severe and areirreversible

• Example: radiationmyelitis

• Measured as risk,therefore not inevitable

• Expected only in very lowfrequency

• Given as % per 5 years

Necrosis

Ulcer

Page 21: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 21/71

IAEA Prevention of accidental exposure in radiotherapy 21

Radiation tolerance doses (cGy)

Page 22: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 22/71

IAEA Prevention of accidental exposure in radiotherapy 22

Late Radiation Morbidity Scoring

ORGANTISSUE

Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 Grade5

SPINALCORD

None Mild L'Hermitte'ssyndrome

Severe L'Hermitte's syndrome Objective neurological findings ator below cord level treated

Mono, para quadraplegia

BRAIN None Mild headacheSlight lethargy

Moderate headache Great lethargy Severe headaches Severe CNSdysfunction (partial loss of poweror dyskinesia)

Seizures or paralysis Coma

LARYNX None HoarsenessSlight arytenoidedema

Moderate arytenoid edema Chondritis Severe edema Severe chondritis Necrosis

LUNG None Asymptomatic ormild symptoms(dry cough)Slight

radiographicappearances

Moderate symptomatic fibrosis orpneumonitis (severe cough) Low gradefever Patchy radiographic appearances

Severe symptomatic fibrosis orpneumonitis Dense radiographicchanges

Severe respiratoryinsufficiency/ Continuous O2/ Assisted ventilation

SMALL &LARGEINTESTINE

None Mild diarrheaMild crampingBowelmovement 5times daily Slightrectal dischargeor bleeding

Moderate diarrhea and colic Bowelmovement >5 times daily Excessiverectal mucus or intermittent bleeding

Obstruction or bleeding requiringsurgery

Necrosis/ Perforation Fistula

LIVER None Mild lassitudeNausea,dyspepsiaSlightlyabnormal liverfunction

Moderate symptoms Some abnormalliver function tests Serum albuminnormal

Disabling hepatitic insufficiencyLiver function tests grosslyabnormal Low albumin Edema orascites

Necrosis/ Hepatic coma orencephalopathy

BLADDER None Slight epithelialatrophy Minortelangiectasia(microscopichematuria)

Moderate frequency Generalizedtelangiectasia Intermittent macroscopichematuria

Severe frequency and dysuriaSevere generalized telangiectasia(often with petechiae) Frequenthematuria Reduction in bladdercapacity (<150 cc)

Necrosis/ Contracted bladder(capacity <100 cc) Severehemorrhagic cystitis

Deathdirectlyrelatedtoradiationeffects

Example for some tissues from the RTOGLate Morbidity Scoring System

Page 23: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 23/71

IAEA Prevention of accidental exposure in radiotherapy 23

Accidental medical exposure

• Under-exposure

• Over-exposure

• Total dose

• Dose per fraction

• Site / area of exposure

• Normal tissue tolerance

• Normal tissue irradiation

Page 24: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 24/71

IAEA Prevention of accidental exposure in radiotherapy 24

Consequences of accidental exposure

• Reduced tumour control rate

• Acute complications

• Late complications

Page 25: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 25/71

IAEA Prevention of accidental exposure in radiotherapy 25

Accidental medical exposure

• Accidental exposure may be• Random (one-off)

• Minimize by double-checking and independentcalculations

• Under-exposure can be compensated by, e.g. accelerated treatment

• Over-exposure may cause increased reaction andalso compromised tumour control

• Systematic• Due to failure of system, e.g. calibration, calculation,

TPS, etc.

Page 26: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 26/71

IAEA Prevention of accidental exposure in radiotherapy 26

Random accidental exposure

• Involves one or a few patients only

• Examples

• Wrong calculation

• Wedge not inserted

• Wedge factor calculation

• Source displacement

• Movement after insertion

• Wrong source strength

• Higher activity than ordered

Page 27: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 27/71

IAEA Prevention of accidental exposure in radiotherapy 27

Systematic accidental exposure

• This is due to failing in the system ofplanning and delivery of radiation therapy

• Includes• Calibration of machine or source

• TPS related

• Systematic manual miscalculation

• More serious than random event as itpotentially affects all patients in a timeperiod

Page 28: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 28/71

IAEA Prevention of accidental exposure in radiotherapy 28

Systematic under-exposure

• Accidental under dosage effects are difficultto detect clinically through reduced sideeffects and may only manifest as poor

tumour control.• May only be apparent years later after audit or

not detected due to change in treatment

patterns• This may involve large number of patients

Case 1: Incomplete understanding

Page 29: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 29/71

IAEA Prevention of accidental exposure in radiotherapy 29

Case 1: Incomplete understandingand testing of a TPS (UK 1982 – 90)

• SSD correction for distance were usually done bythe technologist

• When a new TPS was acquired, same correctioncontinued• however the TPS already corrected for distance

• Therefore double distance correction was donecausing under dosage of up to 30%

• The problem not discovered for 8 years,1045patients affected

• 492 patients developed local recurrence

Page 30: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 30/71

IAEA Prevention of accidental exposure in radiotherapy 30

TCP vs. absorbed dose

Data from Hanks et al 2002

Page 31: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 31/71

IAEA Prevention of accidental exposure in radiotherapy 31

Accidental medical over-exposure

• Over-exposure may be

• Localized

• Related to treatment by EBRT or brachytherapy

• Whole body

• Accidental non-medical exposure, e.g. industrialexposure or public exposure

Page 32: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 32/71

IAEA Prevention of accidental exposure in radiotherapy 32

Localized over-exposure

• Depends on treatment area

• Organ specific but skin usually involved

• Radiation modality

• Photon

• Deeper tissues involved

• Electrons

• Superficial tissues

• Brachytherapy

• Local tissues

Page 33: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 33/71

IAEA Prevention of accidental exposure in radiotherapy 33

Accidental systematic over-exposure

• Wrong calibration of source

• Use of incorrect decay curve for 60Co, USA 1974 –1976

• 22 months of no beam measurement• Reuse of outdated computer file for 60Co

treatment, USA, 1987 –1989

• Beam miscalculation of

60

Co, Costa Rica,1996• During beam calibration reading of the timer wasconfused, leading to underestimation of the dose rate

Page 34: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 34/71

IAEA Prevention of accidental exposure in radiotherapy 34

Accidental systematic over-exposure

• TPS related• Untested change of procedure for data entry into

TPS, Panama, 2000• Calculated treatment time double the normal value

leading to 100% overdose

• Change in practice - use of trimmer bars(computer file not updated, USA, 1987-1988• Patients received 75% higher dose

• Accelerator software problem, USA andCanada,1985-1987

Page 35: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 35/71

IAEA Prevention of accidental exposure in radiotherapy 35

Accidental systematic over-exposure

• Machine related

• Incorrect accelerator repair andcommunication problems, Spain, 1990

• Electron energy was misadjusted• Dose monitoring system

• Białystok incident Poland

Page 36: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 36/71

IAEA Prevention of accidental exposure in radiotherapy 36

Types of overdose

• According to AAPM-Tg35

• Type A > 25% overdose

• Dose range may put patient in LD 50 / 5 range, i.e. 50%risk of death in 5 years

• Type B 5-25% overdose and mostunderdosage

• Not life threatening

• Increased risk of complications or reduced tumourcontrol

Page 37: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 37/71

IAEA Prevention of accidental exposure in radiotherapy 37

Clinical consequences of over-exposure

• Severe over-exposure (off the chart)• Early manifestation of symptoms

• Skin erythema, nausea & vomiting, diarrhea

• Often leads to death

• USA 1974 –1976 300 of 450 died within 1 year

• Panama 2000 8* of 28 died

• USA / Canada 1985 –1987 3 of 6 died

• USA source left in patient 1 of 1 died

• Survivors usually have chronic organ related symptomse.g. diarrhea, bleeding, etc.

• 88% of survivors in USA had severe complications

*5 patients - radiation related

Page 38: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 38/71

IAEA Prevention of accidental exposure in radiotherapy 38

Radiation tolerance doses (cGy)

Page 39: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 39/71

IAEA Prevention of accidental exposure in radiotherapy 39

Clinical consequences of over-exposure

• Skin (Białystok)

• Erythema usually develops after 1 week

• Erythema after few hours

• Moist desquamation (usually does not occur)• Moist desquamation after few weeks

• Ulceration

• 5 of 5 patients• Late effects include fibrosis

M i d i

Page 40: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 40/71

IAEA Prevention of accidental exposure in radiotherapy 40

Moist desquamation

Ul i

Page 41: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 41/71

IAEA Prevention of accidental exposure in radiotherapy 41

Ulceration

N i

Page 42: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 42/71

IAEA Prevention of accidental exposure in radiotherapy 42

Necrosis

Cli i l f

Page 43: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 43/71

IAEA Prevention of accidental exposure in radiotherapy 43

Clinical consequences of over-exposure

• Gastro-intestinal (Panama)• Mild diarrhea (grade 1 – 2) usual

• Severe diarrhea (G3) or necrosis (G4) in at least 20 of 28patients

• 8* patients died

• Symptoms usually resolve by 1 month post radiation

• Chronic symptoms about 100 – 230 days

• Long term

• Bowel stenosis, malabsorbtion, chronic diarrhea & dysentry

* 5 patients - radiation related

B l l ti

Page 44: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 44/71

IAEA Prevention of accidental exposure in radiotherapy 44

Bowel ulceration

B l i

Page 45: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 45/71

IAEA Prevention of accidental exposure in radiotherapy 45

Bowel necrosis

Necrosis

Hemorrhagic rectal mucosa:

Page 46: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 46/71

IAEA Prevention of accidental exposure in radiotherapy 46

Hemorrhagic rectal mucosa:two days before death

St i & b t ti

Page 47: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 47/71

IAEA Prevention of accidental exposure in radiotherapy 47

Stenosis & obstruction

R t l d

Page 48: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 48/71

IAEA Prevention of accidental exposure in radiotherapy 48

Rectal over-dosage

Cli i l f

Page 49: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 49/71

IAEA Prevention of accidental exposure in radiotherapy 49

Clinical consequences of over-exposure

• Nervous system (brain)• Tolerance dose is 50 Gy

• Younger patients with developing brain are at higher

risk• Cerebral atrophy, leucoencephalopathy,

calcification

• Reduced IQ & dementia

• Spasticity

• Necrosis

Leucoencephalopathy

Page 50: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 50/71

IAEA Prevention of accidental exposure in radiotherapy 50

Leucoencephalopathy

Beam miscalibration of 60Co

Page 51: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 51/71

IAEA Prevention of accidental exposure in radiotherapy 51

Beam miscalibration of 60Co

• Whole brain radiation• 8 Gy in 4 fractions

• 50 Gy in 16 fractions

• Dose equivalent• 69.25 Gy (72 Gy)

• Child affected byoverdoses to brain andspinal cord, and the childlost his ability to speak andwalk

Clinical consequences of over exposure

Page 52: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 52/71

IAEA Prevention of accidental exposure in radiotherapy 52

Clinical consequences of over-exposure

• Nervous system (spinal cord)• Tolerance dose is 45 Gy (1-5% risk)

• Serially arranged therefore damage will manifest at

all lower levels• Acute myelitis occurs 2-4 months post-radiation

• Delayed myelopathy occurs at mean of 20months

Patient 80 Undifferentiated Ca Pharynx

Page 53: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 53/71

IAEA Prevention of accidental exposure in radiotherapy 53

Patient 80  – Undifferentiated Ca Pharynx

Spinal cord myelopathy

Page 54: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 54/71

IAEA Prevention of accidental exposure in radiotherapy 54

Spinal cord myelopathy

• Young woman whobecame quadriplegicas a result of

accidentaloverexposure to thespinal cord

• Dose

• 51.7 Gy in 16 #= 64.4 Gy (67.6 Gy)

Clinical consequences of over exposure

Page 55: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 55/71

IAEA Prevention of accidental exposure in radiotherapy 55

Clinical consequences of over-exposure

• Lung• Pneumonitis

• Sub-acute reaction

• Dry cough, dyspnea,

fever• Prolonged course of high

dose steroids required

• 5% risk at 20 Gy

• 50% risk at 30 Gy

• Fibrosis as latecomplication

Other organs

Page 56: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 56/71

IAEA Prevention of accidental exposure in radiotherapy 56

Pleural Effusion Pericardial Effusion

Other organs

Other risks

Page 57: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 57/71

IAEA Prevention of accidental exposure in radiotherapy 57

Other risks

• Heart

• Ischaemic heart disease

• Bladder

• Bleeding, frequency

• Bone

• Fractures, necrosis

• Alopecia

• Non-specific life shortening& pain

Osteo-radionecrosis

Subcutaneousfibrosis

Clinical detection of over exposure

Page 58: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 58/71

IAEA Prevention of accidental exposure in radiotherapy 58

Clinical detection of over-exposure

• Careful clinical follow up may detect accidentaloverdose through early enhanced reactions

• This may be easier in uniform patient population

• Experienced radiation oncologists may be able todetect clinically, during regular weeklyconsultation, dose variations of 10%

• In practice this is difficult due to varying radio-sensitivity

between patients• Some overdoses may cause late severe effects

without abnormal early effects

Clinical detection of over exposure

Page 59: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 59/71

IAEA Prevention of accidental exposure in radiotherapy 59

• In case of unusual reactions of a singlepatient, other patients treated in the sameperiod may need to be recalled

• Re-check all treatment parameters• Check concomitant medications

• Check concomitant therapies

Clinical detection of over-exposure

Evaluation of accidental exposure

Page 60: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 60/71

IAEA Prevention of accidental exposure in radiotherapy 60

Evaluation of accidental exposure

• Determine if emergency or non-emergency• Look for early prodromal symptoms

• Skin may be a clue to radiation injury

• Appear similar to thermal injury but patient hasno recollection of injury

• Associated with intractable pain

Guide for the management of radiation

Page 61: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 61/71

IAEA Prevention of accidental exposure in radiotherapy 61

ginjuries based on early symptoms

Clinical signs Corresponding dose(Gy)

Decisions

WBE LE WBE LE

No vomiting No early erythema <1 <10 Outpatient with five weeksurveillance period (blood, skin)

Vomiting 2-3 hafter exposure

Early erythema orabnormal

sensation 12-24 hafter exposure

1-2 8-15 Surveillance in a general hospital(or outpatient for 3 weeks

followed by hospitalization ifnecessary)

Vomiting 1-2 hafter exposure

Early erythema orabnormalsensation 8-15 hafter exposure

2-4 15-30 Hospitalization in anhaematological or surgical(burns) department

Vomiting earlier

than 1 h afterexposure and/orother severesymptoms e.g. hypotension

Early erythema

within the first 3-6h (or less) afterexposure of skinand/or mucosawith oedema

>4 >30 Hospitalization in a well equipped

haematological or surgicaldepartment with transfer to aspecialized centre forradiopathology

Skin injury

Page 62: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 62/71

IAEA Prevention of accidental exposure in radiotherapy 62

Skin injury

Evaluation of radiation exposure

Page 63: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 63/71

IAEA Prevention of accidental exposure in radiotherapy 63

Evaluation of radiation exposure

• Determine type of exposure• Whole body

• Local

• Inhaled / ingested

• Determine site, exposure dose and number offractions

• Calculate dose equivalent for organ in terms of

Biological Equivalent Dose (BED) and 2 Gy equivalent• Estimate risk of complications according to organ(s)

concerned

Treatment of injuries

Page 64: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 64/71

IAEA Prevention of accidental exposure in radiotherapy 64

Treatment of injuries

• Acute phase• Symptomatic

• Pain relief, antibiotics

• Vasodilators, anti-platelets

• Chronic phase

• Symptomatic

• Pain relief,

• Rehabilitation

• Surgical

• Debridement

• Grafts

Healing of radiation injuries

Page 65: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 65/71

IAEA Prevention of accidental exposure in radiotherapy 65

Healing of radiation injuries

• Depends on extent ofdamage

• Healing by secondaryintention

• Slow process

• Takes months

• Results in scarring

• Results in functionalloss

• Skin, small bowel, etc.

June2001

Dec2001

Progression of late injury

Page 66: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 66/71

IAEA Prevention of accidental exposure in radiotherapy 66

Progression of late injury

• Injuries may worsendue to

• Increasing vascularcompromise

• Infection

• Concomitant disease,e.g. diabetes

• Early surgicalintervention indicated iftumour controlled

June2001

May2002

Surgery for radiation necrosis

Page 67: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 67/71

IAEA Prevention of accidental exposure in radiotherapy 67

Surgery for radiation necrosis

Omentum flap

Skin graft

Lessons learned

Page 68: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 68/71

IAEA Prevention of accidental exposure in radiotherapy 68

Lessons learned

• Working with Awareness and Alertness• Maintain awareness for unusual and complex treatments

• Procedures

• Use comprehensive acceptance, commissioning, qualitycontrol and documentation

• Training and Understanding

• Responsibilities

• Functions and responsibilities should be allocated

Recommendations for prevention

Page 69: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 69/71

IAEA Prevention of accidental exposure in radiotherapy 69

Recommendations for prevention

• A quality assurance program, involving:• Organization

• Education and training

• Acceptance testing and commissioning• Follow up of equipment faults

• COMMUNICATION

• Patients’ identification and charts 

Summary

Page 70: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 70/71

IAEA Prevention of accidental exposure in radiotherapy 70

Summary

• Accidental exposure can be catastrophic and affectmany patients• Effects are often irreversible, progressive and increasing

in frequency• Careful clinical follow-up may detect overdoses of 10%

or more• Underdosage is more difficult to detect clinically

and may affect long term cures• A Quality Assurance program is a key element in

prevention of accidental exposures.• Good communication and lines of responsibility are

essential

References

Page 71: 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

7/31/2019 14-OU Dip RP-AccPr 4.01 Clinical Conseqences Accid Exposures WEB

http://slidepdf.com/reader/full/14-ou-dip-rp-accpr-401-clinical-conseqences-accid-exposures-web 71/71

References

• IAEA publications

• Accidental Overexposure of Radiotherapy Patients in Bialystok(2004)

• Investigation of An Accidental Radiation Exposure of RadiotherapyPatients in Panama (2001)

• Accidental Overexposure of Radiotherapy Patients in San José(1998)

• Safety Report Series No.2• Nuclear Radiation Commission USA reports

• Principles and practice of radiation oncology, Brady & Perez, 4thedition, Lippincott Williams

• Radiobiology for radiologists, E.J. Hall, 5th Edition, Lippincott (2003)

• Hanks G E et al . Dose response in prostate cancer with 8-12 yearsfollow-up, IJROBP 54: 427-435 (2002)

• AAPM report 56. Medical accelerator safety considerations. Report ofAAPM Task Group 35

• TecDoc no 88.